Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities

doi:10.1084/jem.174.6.1593

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Koup, R. A.
	Articles by Sullivan, J. L.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Koup, R. A.
	Articles by Sullivan, J. L.


Social Bookmarking

	What's this?

ARTICLES

Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities

RA Koup, CA Pikora, K Luzuriaga, DB Brettler, ES Day, GP Mazzara and JL Sullivan
Department of Pediatrics, University of Massachusetts Medical School, Worcester 01655.

The presence of cytotoxic T lymphocytes (CTL) to the gag antigens of human immunodeficiency virus (HIV) has been described in infected populations. We found that the majority of this immune response as measured in bulk CTL assays of unstimulated peripheral blood mononuclear cells (PBMC) is directed against the p24 component of the p55 gag precursor protein. Using limiting dilution analysis of this effector cell population we confirm that the majority of activated gag- specific CTL circulating in the PBMC of infected hemophilic patients are directed at p24 determinants and are present at frequencies of 1/36,000 to 1/86,000 lymphocytes. By performing in vitro stimulation after limiting dilution, the precursor population of gag-specific CTL are characterized and quantitated. HIV gag-specific CTL precursors are identified at frequencies of 1/1700 to 1/17,000 lymphocytes and are made up of cells with both p17 and p24 specificities. No HIV gag- specific CTL precursor cells are identified in the PBMC of HIV- uninfected individuals. These studies demonstrate that CTL directed at both p17 and p24 determinants make up the cellular immune repertoire in HIV-infected individuals but that only the p24-specific CTL are routinely found in an activated state in the circulation.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Mollet, L., Li, T.-S., Samri, A., Tournay, C., Tubiana, R., Calvez, V., Debre, P., Katlama, C., Autran, B. (2000). Dynamics of HIV-Specific CD8+ T Lymphocytes with Changes in Viral Load. J. Immunol. 165: 1692-1704 [Abstract] [Full Text]
Sewell, A. K., Price, D. A., Oxenius, A., Kelleher, A. D., Phillips, R. E. (2000). Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus: Control and Escape. Stem Cells 18: 230-244 [Abstract] [Full Text]
Alexander, L., Weiskopf, E., Greenough, T. C., Gaddis, N. C., Auerbach, M. R., Malim, M. H., O'Brien, S. J., Walker, B. D., Sullivan, J. L., Desrosiers, R. C. (2000). Unusual Polymorphisms in Human Immunodeficiency Virus Type 1 Associated with Nonprogressive Infection. J. Virol. 74: 4361-4376 [Abstract] [Full Text]
Dalod, M., Dupuis, M., Deschemin, J.-C., Sicard, D., Salmon, D., Delfraissy, J.-F., Venet, A., Sinet, M., Guillet, J.-G. (1999). Broad, Intense Anti-Human Immunodeficiency Virus (HIV) Ex Vivo CD8+ Responses in HIV Type 1-Infected Patients: Comparison with Anti-Epstein-Barr Virus Responses and Changes during Antiretroviral Therapy. J. Virol. 73: 7108-7116 [Abstract] [Full Text]
Kalams, S. A., Buchbinder, S. P., Rosenberg, E. S., Billingsley, J. M., Colbert, D. S., Jones, N. G., Shea, A. K., Trocha, A. K., Walker, B. D. (1999). Association between Virus-Specific Cytotoxic T-Lymphocyte and Helper Responses in Human Immunodeficiency Virus Type 1 Infection. J. Virol. 73: 6715-6720 [Abstract] [Full Text]
Kalams, S. A., Goulder, P. J., Shea, A. K., Jones, N. G., Trocha, A. K., Ogg, G. S., Walker, B. D. (1999). Levels of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Effector and Memory Responses Decline after Suppression of Viremia with Highly Active Antiretroviral Therapy. J. Virol. 73: 6721-6728 [Abstract] [Full Text]
Wasik, T. J., Bratosiewicz, J., Wierzbicki, A., Whiteman, V. E., Rutstein, R. R., Starr, S. E., Douglas, S. D., Kaufman, D., Sison, A. V., Polansky, M., Lischner, H. W., Kozbor, D. (1999). Protective Role of {beta}-Chemokines Associated with HIV-Specific Th Responses Against Perinatal HIV Transmission. J. Immunol. 162: 4355-4364 [Abstract] [Full Text]
McFarland, E. J., Harding, P. A., MaWhinney, S., Schooley, R. T., Kuritzkes, D. R. (1998). In Vitro Effects of IL-12 on HIV-1-Specific CTL Lines from HIV-1-Infected Children. J. Immunol. 161: 513-519 [Abstract] [Full Text]
Kmieciak, D., Wasik, T. J., Teppler, H., Pientka, J., Hsu, S. H., Takahashi, H., Okumura, K., Kaneko, Y., Kozbor, D. (1998). The Effect of Deletion of the V3 Loop of gp120 on Cytotoxic T Cell Responses and HIV gp120-Mediated Pathogenesis. J. Immunol. 160: 5676-5683 [Abstract] [Full Text]
Kuroda, M. J., Schmitz, J. E., Barouch, D. H., Craiu, A., Allen, T. M., Sette, A., Watkins, D. I., Forman, M. A., Letvin, N. L. (1998). Analysis of Gag-specific Cytotoxic T Lymphocytes in Simian Immunodeficiency Virus-infected Rhesus Monkeys by Cell Staining with a Tetrameric Major Histocompatibility Complex Class I-Peptide Complex. J. Exp. Med. 187: 1373-1381 [Abstract] [Full Text]
Connor, R. I., Korber, B. T.�M., Graham, B. S., Hahn, B. H., Ho, D. D., Walker, B. D., Neumann, A. U., Vermund, S. H., Mestecky, J., Jackson, S., Fenamore, E., Cao, Y., Gao, F., Kalams, S., Kunstman, K. J., McDonald, D., McWilliams, N., Trkola, A., Moore, J. P., Wolinsky, S. M. (1998). Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1�while Participating in Trials of Recombinant gp120 Subunit Vaccines. J. Virol. 72: 1552-1576 [Abstract] [Full Text]
Musey, L., Hughes, J., Schacker, T., Shea, T., Corey, L., McElrath, M. J. (1997). Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 Infection. NEJM 337: 1267-1274 [Abstract] [Full Text]
Ferrari, G., Berend, C., Ottinger, J., Dodge, R., Bartlett, J., Toso, J., Moody, D., Tartaglia, J., Cox, W. I., Paoletti, E., Weinhold, K.J. (1997). Replication-Defective Canarypox (ALVAC) Vectors Effectively Activate Anti-Human Immunodeficiency Virus-1 Cytotoxic T Lymphocytes Present in Infected Patients: Implications for Antigen-Specific Immunotherapy. Blood 90: 2406-2416 [Abstract] [Full Text]
Pikora, C. A., Sullivan, J. L., Panicali, D., Luzuriaga, K. (1997). Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants. J. Exp. Med. 185: 1153-1162 [Abstract] [Full Text]
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., Davis, M. M. (1996). Phenotypic Analysis of Antigen-Specific T Lymphocytes. Science 274: 94-96 [Abstract] [Full Text]